NORML

JANUARY 31, 2019

Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate. Twenty percent of those surveyed acknowledged having previously used cannabis for medical purposes.

Clinical Trials 193

Clinical Trials Chronic Pain Data Treatment 193

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. According to the announcement, Biodata—a subsidiary of Labat Africa—“is the brainchild of Dr. The pilot results of the study were very promising, as it showed 98% of the patients have some sort of pain relief from cannabis.”.

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113

Cannabis Law Report

OCTOBER 6, 2021

Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Events 52

The Cannigma

MAY 9, 2023

However, in 2019, the Jordanian government announced its plans to conduct clinical trials on the use of cannabis for medical purposes. However, the government’s recent announcement of clinical trials on medical cannabis could be a sign of change in the future.

Law 52

Law Clinical Trials Chronic Pain Recreational 52

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Canna Care Docs

OCTOBER 3, 2023

This may include opiates for chronic pain, anti-nausea medication, and even antidepressants. These symptoms include: Loss of appetite Fatigue or insomnia Nausea and vomiting Constipation Difficulty Breathing Chronic pain Weight loss General weakness of muscle A terminal illness diagnosis can immensely impact a patient and their family.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

MMJ Recs

MAY 9, 2024

Many veterans struggle with various physical and psychological conditions resulting from their service. These professionals can provide valuable insights into whether medical cannabis is a suitable option based on the veteran’s medical history, current conditions, and treatment goals.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

NewsMunchies

AUGUST 25, 2021

Chronic pain represents an emerging public health issue. It is a way of life for those suffering with debilitating medical conditions that bring about widespread body aches, joint pain, and muscle tension. On the pain scale, I’d rank it somewhere between almost screaming and needing to be sedated.

CBD 98

CBD Chronic Pain Clinical Trials Oil 98

FloridaMarijuana.net

AUGUST 15, 2018

Neuropathic pain is chronic pain made prevalent by tissue injury. Other symptoms include : Pain or cramping, especially of the hands, feet or calf muscles. The American Chronic Pain Association (ACPA) states that “with neuropathic pain, the nerve fibers themselves might be damaged, dysfunctional, or injured.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

Cannabis Law Report

JUNE 25, 2021

Department of Veterans Affairs (VA) to run clinical trials on the potential benefits of cannabis for the treatment of military veterans suffering from post-traumatic stress disorder (PTSD) and chronic pain. The Senate Veterans’ Affairs Committee reviewed a bill that would ask the U.S. Source: [link].

Clinical Trials 66

Clinical Trials Chronic Pain Legislation Treatment 66

Cannabis Law Report

SEPTEMBER 9, 2021

MYMD-1 is also being developed as a potential therapy for COVID-19-related conditions such as post-COVID-19 syndromes. Supera-CBD is being developed to address anxiety, chronic pain, addiction, and seizures, and is on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain.

Pharmaceutical 97

Pharmaceutical Clinical Trials Chronic Pain Epilepsy 97

The Cannigma

MAY 13, 2022

One of the most common uses of medical cannabis is to treat chronic pain. In fact, modern research on cannabis and pain dates back to before 1975. Over 10% of US adults have suffered from some degree of daily pain for at least three months, so the need for improved treatment is clear.

Terpenes 111

Terpenes Strains Chronic Pain Clinical Trials 111

Cannabis Law Report

JANUARY 12, 2022

. “Gb Sciences has established a pipeline of patent-protected combination therapies for the treatment of medical conditions affecting hundreds of millions of people,” said Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences. ” Gb Sciences’ intellectual property portfolio includes five U.S.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

FloridaMarijuana.net

JUNE 13, 2018

As the skin absorbs the pain-relieving compounds, the pain is blocked, but without affecting other parts of your body. Often, skin cancer or dermatological patients benefit from this method, however those with chronic pain and inflammation may benefit as well.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Veriheal

SEPTEMBER 18, 2020

Professor Luke Henderson is set to be the study’s lead investigator and he explains that the unfortunate truth for more than half of spinal cord injury patients is the development of chronic pain. By looking at the changes in the brain, the team of researchers will be able to identify the development of chronic neuropathic pain.

Treatment 98

Treatment Chronic Pain Research and Development CBD 98

MMJ Recs

NOVEMBER 20, 2023

Both THC and CBD have demonstrated analgesic properties, making them valuable for managing chronic pain conditions such as arthritis, fibromyalgia, and cancer-related pain. CBD’s anti-seizure properties, demonstrated through clinical trials, have made it a game-changer in the epilepsy field.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

FEBRUARY 7, 2020

The study by researchers from the University of Auckland and medical cannabis clinic owner Dr Graham Gulbransen looked at how patients were faring after using cannabidiol (CBD), the non-intoxicating compound in cannabis that has had so much attention these past few years. reported a worsening of a pre-existing condition.

Chronic Pain 59

Chronic Pain Clinical Trials Conditions Patients 59

Cannabis Law Report

MAY 10, 2022

Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. Since the beginning of the program, medicinal cannabis has been prescribed for over 140 conditions.

Medicine 52

Medicine Clinical Trials Sleep Data 52

The Joint Blog

FEBRUARY 11, 2022

With more corners of the world coming around and legalizing the use of CBD for research and treatment of various conditions, a greater understanding of its potential for good is just now becoming apparent. This includes clinical trials on humans. Does this mean that CBD is a cure for a virus? And on grander scales.

Clinical Trials 49

Clinical Trials CBD Conditions Data 49

Veriheal

MAY 3, 2022

The team sought to answer the following: “What are the risks and benefits of obtaining a medical marijuana card for adults who seek medical marijuana for pain, insomnia and anxiety or depressive symptoms?”—a Clinical Trial Sample Size. a necessary question to address as medical marijuana becomes more accessible.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Cannabis Law Report

AUGUST 26, 2019

Over the years, research has generated results to suggest that marijuana benefits in the treatment of some conditions. Chronic pain. One area that reports looked closely was, use of medical marijuana to treat chronic pain. The drug for treating such conditions involves a purified form of CBD.

Chronic Pain 45

Chronic Pain Clinical Trials Epilepsy Conditions 45

Cannabis Law Report

JUNE 21, 2021

Most of the data came from five states that list these indications as qualifying conditions for the use of medical cannabis. Taking the doctor-patient use of RYAH devices one step further, organizations conducting clinical trials are finding value in the company’s offerings.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

AUGUST 26, 2022

In addition, while many people rely on northern lights strains and other Indica strains of cannabis to tackle depression, the use of CBD has been proven to extend to chronic pain relief. Apart from this, various clinical trials are done for multiple conditions. Seizures and epilepsy are serious medical conditions.

Epilepsy 52

Epilepsy Treatment CBD Sleep 52

Canna Care Docs

DECEMBER 16, 2020

Medical marijuana is the use of the marijuana plant or its chemicals to treat various diseases or conditions. What conditions is medical marijuana helpful for? While research is ongoing, existing studies and anecdotal evidence show that medical cannabis is useful for a variety of conditions, both physical and psychiatric.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

AUGUST 6, 2021

Clinical trials have shown that small doses of CBD help people to manage their social anxiety. THC has been shown to be just as effective as codeine in terms of pain relief. If you suffer from spinal cord injuries, multiple sclerosis-associated pain, chronic pain, or regular muscle pain, then you’ll benefit from taking CBD.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

Cannabis Law Report

AUGUST 24, 2021

The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. MYMD-1 is being developed to treat aging and longevity, autoimmune diseases, and COVID-19- associated depression and cytokine elevation.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

The Cannigma

MAY 1, 2023

2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. Ketamine was approved by the FDA in 1970 and was immediately put to use as an important tool for war medics in the Vietnam War. Is ketamine safe?

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

Cannabis Law Report

JUNE 8, 2021

This SRA will leverage four other clinical trials being planned by the university, to determine the effects of psilocybin on inflammatory markers of patients who have exhibited Parkinson’s, Bipolar disorder, and chronic back pain.

Patients 92

Patients Research and Development Clinical Trials Chronic Pain 92

Cannabis Law Report

DECEMBER 28, 2021

The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., This is because Epidiolex has been proven an effective treatment after going through various clinical trials. after its consumption.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

Cannabis Law Report

OCTOBER 19, 2021

The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. About MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Cannabis Law Report

AUGUST 28, 2022

How can cannabinoids be used to treat various medical conditions? Cannabinoids have been shown to have therapeutic potential for a variety of medical conditions, including pain, inflammation, anxiety, and seizures. ADB-BUTINACA is a cannabinoid that has been shown to be effective in treating a range of medical conditions.

Cannabinoids 52

Cannabinoids Trichome Treatment Clinical Trials 52

Cannabis Law Report

OCTOBER 5, 2021

The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases and COVID-19- associated depression.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Media 52

Cannabis Law Report

DECEMBER 1, 2021

The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. About MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

SEPTEMBER 22, 2021

At 8,000 times the potency of regular CBD, we believe that Supera-CBD shows strong potential as a therapeutic for high-threat diseases and conditions like Alzheimer’s, psychosis, neuropathic pain, addiction, and anxiety. Chris Chapman, M.D., About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

NOVEMBER 25, 2021

The Food and Drug Administration (FDA) recently approved the use of CBD to help treat the condition in individuals as young as two years old. Depression and anxiety are serious mental health conditions that should be taken seriously. Chronic Pain. Thus far, few indications of negative side effects have been found.

CBD 52

CBD Clinical Trials Epilepsy Chronic Pain 52

Veriheal

JULY 12, 2021

As a veteran, being able to get past the PTSD involves transitioning out of the mental and emotional war zone, which is challenging and the reason why veterans seek out multiple methods to deal with the condition. A study conducted by Miriam Reisman reported that between 13.5% What Is The Latest Research for Veterans and PTSD?

Treatment 104

Treatment Sleep Clinical Trials Data 104

MMJ Recs

DECEMBER 22, 2023

Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. One significant factor is the recognition of the opioid crisis and the need for alternative pain management strategies.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52